Methylergonovine Maleate Injection

What is Methylergonovine Maleate Injection?
Methylergonovine Maleate Injection is an ergot alkaloid uterotonic used for the prevention and treatment of postpartum hemorrhage (PPH) due to uterine atony or subinvolution. By stimulating uterine smooth muscle contractions, it helps control excessive bleeding after childbirth. It is widely included in maternal health protocols across hospitals and emergency obstetric care units.
 
Uses of Methylergonovine Maleate Injection
Prevention and treatment of postpartum hemorrhage (PPH)
Management of uterine atony
Control of subinvolution of the uterus
Supportive therapy in obstetric surgeries such as cesarean section
Rapid uterine contraction in obstetric emergencies
 
How Does Methylergonovine Maleate Injection Work?
Methylergonovine acts directly on the smooth muscle of the uterus, causing rapid and sustained contractions. This uterotonic effect reduces uterine bleeding and promotes involution of the uterus after delivery.
 
Frequently Asked Questions (FAQs)
Q: What is Methylergonovine Maleate Injection used for? A: Methylergonovine Maleate Injection is a potent uterotonic (ergot alkaloid) used primarily in obstetrics. It is indicated for the prevention and treatment of postpartum hemorrhage (PPH) caused by uterine atony (failure of the uterus to contract) or subinvolution. It helps stimulate rapid and sustained uterine contractions to control excessive bleeding after childbirth.
Q: Who is a top manufacturer of Methylergonovine Maleate Injection in India?
A: Farbe Firma Pvt. Ltd. is a leading manufacturer and supplier of Methylergonovine Maleate Injection (Trade Name: Ergosyl). We manufacture this critical maternal health drug in our WHO-GMP certified facility, ensuring high stability and potency for emergency obstetric care globally.
Q: In what strength and packing is Ergosyl (Methylergonovine) available?
A: We manufacture Methylergonovine Maleate Injection in the standard strength of 0.2 mg/ml. It is typically available in 1 ml ampoules, which are cold-chain protected to maintain efficacy.
Q: How does Methylergonovine differ from Oxytocin?
A: While both are uterotonics, Methylergonovine causes sustained, tetanic contractions of the uterus, making it highly effective for controlling bleeding after delivery of the placenta. It is typically used when oxytocin alone is insufficient or as a second-line agent for PPH management.
Q: Do you offer Contract Manufacturing for Methylergonovine Injection?
A: Yes, Farbe Firma Pvt. Ltd. offers specialized Contract Manufacturing (CMO) services for gynecological injectables. We provide comprehensive support, including cold-chain manufacturing, sterile filling, and regulatory dossier compilation (CTD/ACTD) to help you market the product under your own brand.
 
Looking for a reliable Methylergonovine Maleate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for trusted maternal health injectables, dossier support, and worldwide export solutions.